Search filters

List of works by Peter C. Fuchs

Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime

scientific article published on 01 January 1989

Ampicillin-sulbactam susceptibility testing criteria.

scientific article

An in vitro evaluation of HRE 664, a novel penem antibiotic.

scientific article published in September 1988

Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin

scientific article published in November 1991

Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin

scientific article published on 01 February 1997

Antibacterial activity of PD 131628 and proposed disc diffusion susceptibility test criteria

scientific article published on 01 June 1994

Antibacterial activity of WY-49605 compared with those of six other oral agents and selection of disk content for disk diffusion susceptibility testing

scientific article

Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility tests

scientific article published on 01 April 1999

Antimicrobial Susceptibility Tests with Cefotaxime and Correlation with Clinical Bacteriologic Response

scientific article published on September 1, 1982

Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399

scientific article published on April 1993

Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates

scientific article published on 01 January 1980

Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates

scientific article published on December 1986

Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates

scientific article published on 01 March 1987

Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control

scientific article published on 01 January 1988

Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods

scientific article published on December 1986

Antimicrobial activity of cefpirome. An update compared to five third-generation cephalosporins against nearly 6000 recent clinical isolates from five medical centers.

scientific article

Antipneumococcal Activities of a Ketolide (HMR 3647), a Streptogramin (Quinupristin-Dalfopristin), a Macrolide (Erythromycin), and a Lincosamide (Clindamycin)

scientific article published on April 1, 1998

Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin

scientific article published on 01 March 1991

Are ciprofloxacin susceptibility tests relevant for Streptococcus pneumoniae?

scientific article published on 01 July 1996

BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.

scientific article

BL-S786, a new parenteral cephalosporin. II. In vitro antimicrobial activity comparison with six related cephalosporins

scientific article published on July 1, 1977

BO-2727, meropenem and imipenem disc diffusion susceptibility testing criteria

scientific article published on 01 August 1995

Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator

scientific article

CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria

scientific article published on 01 March 1987

Cefaclor and Cefatrizine, New Investigational Orally Administered Cephalosporins: ln-vitro Collaborative Evaluation Against Clinical Bacterial Isolates and Comparison with Related Antimicrobics

scientific article published on 01 October 1979

Cefditoren in vitro activity and spectrum: a review of international studies using reference methods

scientific article published on September 1, 2001

Cefixime disk susceptibility test criteria

scientific article published on October 1986

Cefmenoxime (SCE-1365), a new Cephalosporin: In Vitro Activity, Comparison with Other Antimicrobial Agents, Beta-Lactamase Stability, and Disk Diffusion Testing with Tentative Interpretive Criteria

scientific article published on December 1, 1981

Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicin

scientific article

Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing

scientific article published on July 1, 1980

Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing

scientific article published on November 1982

Cefotiam susceptibility testing criteria

scientific article published on December 1985

Cefpiramide: comparative in-vitro activity and beta-lactamase stability

scientific article published on 01 September 1985

Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests

scientific article published on September 1981

Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.

scientific article

Ceftizoxime: collaborative multiphased in-vitro evaluation including tentative interpretive standards for disc susceptibility tests, -lactamase stability, and inhibition

scientific article published on 01 November 1982

Cefuroxime disc susceptibility test criteria for Streptococcus pneumoniae

scientific article published on 01 August 1996

Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates

scientific article published on July 1, 1977

Cefuroxime, an in vitro Comparison with Six Other Cephalosporins

scientific article published on January 1, 1977

Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers a reevaluation after five years

scientific article published on March 1, 1995

Comparative in vitro antimicrobial activity of a new carbapenem, E1010, and tentative disc diffusion test interpretative criteria

scientific article published in July 2001

Comparison of agar media used for determining antimicrobial susceptibility of Neisseia gonorrhoeae

scientific article published on 01 July 1991

Comparison of amino acid decarboxylase and dihydrolase results by Moeller, rapid, and replicator plate methods

scientific article published on January 1976

Comparison of fixed concentration and fixed ratio options for dilution susceptibility testing of gram-negative bacilli to ampicillin and ampicillin/sulbactam.

scientific article

Comparison of fixed concentration and fixed ratio options for testing susceptibility of gram-negative bacilli to piperacillin and piperacillin/tazobactam

scientific article published on 01 August 1992

Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus species

scientific article published on 01 March 1994

Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates

scientific article published on June 1, 1976

Cross-resistance and cross-susceptibility between fluoroquinolone agents

scientific article published on December 1, 1991

Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests.

scientific article published in September 2000

Desacetylcefotaxime--another broad spectrum cephalosporin?

scientific article

Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters

scientific article published on 01 March 1993

Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid

scientific article published on April 1984

Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).

scientific article published on August 1986

Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories

scientific article published on September 1984

Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria

scientific article published on 01 September 1987

Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: A multicenter study

scientific article published on 01 January 1988

Effect of minor pH changes on the in-vitro activity of azithromycin and clarithromycin

scientific article published on 01 January 1997

Error rates in cefoperazone and cefoperazone-sulbactam disk tests with Enterobacteriaceae and Pseudomonas aeruginosa

scientific article published on October 1, 1992

Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media

scientific article

Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime

scientific article

Evaluation of disk susceptibility testing of fosfomycin tromethamine.

scientific article

Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.

scientific article

Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid

scientific article published on June 1, 1988

Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin

scientific article published on May 1985

Fluoroquinolone resistance among recent clinical isolates of Streptococcus pneumoniae

scientific article published on 01 March 1999

Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolates

scientific article published on December 1, 1979

Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methods

scientific article published on 01 January 1999

Haemophilus test medium versus Mueller-Hinton broth with lysed horse blood for antimicrobial susceptibility testing of four bacterial species

scientific article published on 01 July 1993

Identification and antimicrobial susceptibility of 250 Bacteriodes fragilis subspecies tested by broth microdilution methods

scientific article published on April 1, 1976

Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media

scientific article

Implications of beta-lactamase-inhibitor combinations.

scientific article published in March 1990

In Vitro Activities of Clinafloxacin against Contemporary Clinical Bacterial Isolates from 10 North American Centers

scientific article published on May 1, 1998

In Vitro Activities of the Ketolide HMR 3647 against Recent Gram-Positive Clinical Isolates and Haemophilus influenzae

scientific article published on August 1, 1998

In Vitro Antimicrobial Activity of MSI-78, a Magainin Analog

scientific article published on May 1, 1998

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

scientific article

In vitro activities of SCH27899 alone and in combination with 17 other antimicrobial agents

scientific article

In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens

scientific article

In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers

scientific article

In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers

scientific article

In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents

scientific article

In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacin

scientific article

In vitro activities of three nonfluorinated quinolones against representative bacterial isolates

scientific article

In vitro activity and disk susceptibility of Timentin: current status

scientific article published in November 1985

In vitro activity and selection of disk content for disk diffusion susceptibility tests with trovafloxacin

scientific article published on 01 August 1996

In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agents.

scientific article

In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101

scientific article published on 01 December 1988

In vitro activity of ampicillin, amoxicillin, ampicillin-sulbactam, and amoxicillin-clavulanic acid against consecutive clinical isolates of Enterobacteriaceae.

scientific article

In vitro activity of an orally administered streptogramin (RPR 106,972) compared to quinupristin/dalfopristin and erythromycin

scientific article published on 01 February 1997

In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates

scientific article published on 01 November 1986

In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods

scientific article published on 01 April 1996

In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers

scientific article published on 01 November 1993

In vitro activity of gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteria

scientific article published on 01 December 2000

In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime

scientific article published in February 2002

In vitro activity of the ketolide ABT-773

scientific article

In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides againstStreptococcus pneumoniae andHaemophilus influenzae

scientific article published on October 1, 1997

In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates

scientific article

In vitro activity of trovafloxacin against ciprofloxacin-susceptible and -resistant clinical bacterial isolates and assessment of the trovafloxacin disk test.

scientific article

In vitro antibacterial spectrum of E1040 compared with those of cefpirome and ceftazidime and disk diffusion interpretive criteria for E1040.

scientific article

In vitro antimicrobial activity comparison of cefaclor (compound 99638), cephradine, and cephalothin

scientific article published on September 1, 1977

In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates

scientific article published on July 1, 1976

In vitro antimicrobial activity of tigemonam, a new orally administered monobactam

scientific article

In vitro bactericidal activity of daptomycin against staphylococci

scientific article published in March 2002

In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits

scientific article published on July 1983

In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria

scientific article published on 01 July 1986

In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations

scientific article published on January 1991

In vitro susceptibility testing procedures for fosfomycin tromethamine

scientific article

In-vitro activity of five beta-lactam/beta-lactamase inhibitor combinations against consecutive isolates of the Enterobacteriaceae and Pseudomonas aeruginosa

scientific article published on 01 February 1994

In-vitro activity of four penicillin/beta-lactamase inhibitor combinations against cefoxitin-susceptible and cefoxitin-resistant Bacteroides fragilis isolates.

scientific article

In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests

scientific article published on 01 May 1999

In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.

scientific article published in June 1985

In-vitro potency of azithromycin against Gram-negative bacilli is method-dependent

scientific article published on 01 October 1991

In-vitro selection of quinolone-resistant staphylococcal mutants by a single exposure to ciprofloxacin or trovafloxacin (CP-99,219) -letter-

scientific article published on 01 August 1996

In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits

scientific article published on 01 February 1996

Influence of the test medium on azithromycin and erythromycin regression statistics

scientific article published on 01 October 1991

Influence of variations in test methods on susceptibility of Haemophilus influenzae to ampicillin, azithromycin, clarithromycin, and telithromycin

scientific article

Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal

scientific article

Interpretative criteria and quality control parameters for telithromycin disc diffusion susceptibility tests

scientific article published in July 2001

Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.

scientific article

Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.

scientific article published on January 1995

Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.

scientific article published on January 1997

Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin

scientific article published on November 1, 1992

Interpretive criteria for antimicrobial susceptibility tests with cefodizime discs

scientific article

Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic

scientific article published on March 1990

Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid

scientific article

Interpretive criteria for temocillin disk diffusion susceptibility testing.

scientific article

Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae.

scientific article published in November 1990

Is Escherichia coli ATCC 25922 useful for monitoring broth microdilution tests of fluoroquinolones?

scientific article

LY164846 in vitro antimicrobial activity testing, including disk diffusion susceptibility tests using 30-microgram disks

scientific article published on March 1986

Lack of effect of antibiotic resistance on susceptibility of microorganisms to chlorhexidine gluconate or povidone iodine.

scientific article

Levofloxacin disk potency and tentative interpretive criteria for susceptibility tests

scientific article published on July 1993

Lincomycin disc susceptibility testing criteria.

scientific article published in June 1990

Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA

scientific article published on 01 July 1997

Methods for predicting susceptibility of Streptococcus pneumoniae to cefixime

scientific article published on April 1995

Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacin

scientific article published on 01 June 1993

Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parameters

scientific article published on 01 August 1996

Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing

scientific article published on August 1981

Moxalactam (LY127935), a new semisynthetic 1-oxa-beta-lactam antibiotic with remarkable antimicrobial activity: in vitro comparison with cefamandole and tobramycin

scientific article published on April 1980

Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolates

scientific article published on April 1991

Multicenter in vitro evaluation of SM-7338, a new carbapenem

scientific article

Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing.

scientific article

Multicenter survey of the in vitro activity of four expanded-spectrum beta-lactams against consecutive contemporary clinical isolates

scientific article published on 01 December 1998

Multilaboratory evaluation of an agar diffusion disk susceptibility test for rapidly growing anaerobic bacteria

scientific article published on 01 January 1990

Multilaboratory evaluation of the in vitro activity of 13 beta-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria

scientific article published on 01 March 1993

Multiple-Inocula (Replicator) CAMP Test for Presumptive Identification of Group B Streptococci

scientific article published on February 1, 1978

Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.

scientific article published on January 1989

PMX-622 (Polymyxin B-Dextran 70) Does Not Alter In Vitro Activities of 11 Antimicrobial Agents

scientific article published on October 1, 1998

Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin

scientific article published on 01 December 1977

Piperacillin and carbenicillin; a collaborative in vitro comparison against 10,838 clinical bacterial isolates

scientific article published on January 1, 1979

Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains

scientific article published on 01 November 1989

Pneumococcal susceptibility to meropenem

scientific article published on 01 May 1996

Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods

scientific article

Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990.

scientific article published in December 1990

Prevalence of resistance to three fluoroquinolones: assessment of levofloxacin disk test error rates and surrogate predictors of levofloxacin susceptibility. AST Surveillance Group

scientific article

Proposed disk diffusion susceptibility criteria for ofloxacin.

scientific article published on August 1985

Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae

scientific article published on April 1992

Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.

scientific article published on October 1991

Provisional interpretive criteria for quinupristin/dalfopristin susceptibility tests

scientific article published on 01 May 1997

Provisional quality control parameters and interpretive criteria for testing susceptibility ofStreptococcus pneumoniae andHaemophilus influenzae to quinupristin/dalfopristin (RP59500)

scientific article published on 01 March 1998

Quality Control Limits for Dilution and Disk Diffusion Susceptibility Tests of Trovafloxacin against Eight Quality Control Strains

scientific article published on February 1, 1998

Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria

scientific article published on January 1989

Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.

scientific article published on July 1981

Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid

scientific article published on 01 May 1987

Quality control limits for microdilution susceptibility tests with norfloxacin.

scientific article published on January 1987

Quality control limits for the standard anaerobic reference agar dilution susceptibility test procedure of the National Committee for Clinical Laboratory Standards

scientific article published on January 1989

Quality control parameters for broth microdilution susceptibility testing of amoxicillin and amoxicillin-clavulanic acid.

scientific article

Quality control parameters for cefditoren susceptibility tests

scientific article published in February 2001

RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteria

scientific article published on 01 May 1987

RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteria.

scientific article

RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci

scientific article published in March 1993

Ramoplanin susceptibility testing criteria

scientific article published on July 1993

Reassessment of methods for testing the susceptibility of Haemophilus influenzae to clarithromycin

scientific article published on 01 April 1996

Reassessment of susceptibility test interpretive criteria for ticarcillin and ticarcillin-clavulanic acid

scientific article

Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins

scientific article published on December 1, 1978

Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.

scientific article

Relative potencies of azithromycin, clarithromycin and five other orally administrated antibiotics

scientific article published on 01 April 1995

Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.

scientific article published in July 2001

Reproducibility of broth microdilution and disk diffusion susceptibility tests of nine antimicrobial agents against Streptococcus pneumoniae ATCC 49619

scientific article published on 01 May 1997

Revision of quality control limits for broth microdilution tests of fleroxacin and gentamicin with Pseudomonas aeruginosa ATCC 27853

scientific article published on 01 December 1994

Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidis

scientific article published on September 1979

Selection of a fluoroquinolone-class disk for susceptibility tests.

scientific article

Selection of a reference lot of Mueller-Hinton agar

scientific article published on July 1986

Selection of zone size interpretive criteria for disk diffusion susceptibility tests of three antibiotics against Streptococcus pneumoniae, using the New Guidelines of the National Committee for Clinical Laboratory Standards

scientific article

Spontaneously occurring staphylococcal mutants resistant to clinically achievable concentrations of ciprofloxacin and temafloxacin

scientific article published on March 1, 1992

Stability of antimicrobials in Schaedler's anaerobic and brain heart infusion broths stored at -20.DEG.C

scientific article published on March 1, 1978

Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline

scientific article published on December 1989

Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group

scientific article

Streptococcus pneumoniaeKilling Rate and Post-Antibiotic Effect of Levofloxacin and Ciprofloxacin

scientific article published on 01 December 1997

Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae

scientific article published on October 1996

Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance Group.

scientific article

Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid

scientific article published on January 1993

Susceptibility of Haemophilus influenzae to clarithromycin alone and in combination with its 14-hydroxy metabolite

scientific article published on 01 December 1991

Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests

scientific article published on March 1993

Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.

scientific article published in August 2000

Susceptibility of bacterial respiratory pathogens to amoxicillin and amoxicillin-clavulanic acid

scientific article published on 01 May 1994

Susceptibility of multi-resistant Streptococcus pneumoniae to ciprofloxacin, ofloxacin and levofloxacin

scientific article published on 01 May 1997

Susceptibility testing quality control studies with fosfomycin tromethamine

scientific article published on July 1, 1997

Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres

scientific article published in November 1998

Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains

scientific article published on 01 January 1984

Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters

scientific article published on September 1993

Tentative criteria for determining the in vitro susceptibilities of Haemophilus influenzae, including quality control parameters, to two fluoroquinolones (grepafloxacin and PD 131628)

scientific article published on March 1, 1995

Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.

scientific article published on March 1986

Tentative disk diffusion susceptibility interpretive criteria for pefloxacin

scientific article published on September 1986

Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116))

scientific article published on 01 January 1996

Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacin

scientific article published on August 1993

Tentative interpretive criteria for testing the susceptibility of Streptococcus pneumoniae to eight fluoroquinolones

scientific article published on September 1996

Tests for susceptibility of Streptococcus pneumoniae to cefdinir: proposed interpretive criteria and quality control parameters for both microdilution and disc diffusion methods

scientific article published on 01 November 1995

The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam

scientific article published in November 1986

The antibacterial activity of co-amoxiclav

scientific article published on 01 April 1993

Ticarcillin and Ticarcillin-Clavulanic Acid Susceptibility Tests: Error Rates for Disk Tests with Consecutively Isolated Members of the Family

scientific article published in 1992

Ticarcillin and ticarcillin-clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated members of the family Enterobacteriaceae

scientific article published on January 1, 1992

Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins

scientific article published on 01 December 1977

Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates

scientific article published on November 1, 1977